Mechanisms of growth failure in non-growth-hormone deficient children of short stature

Hormone Research in Paediatrics

Volumn 48, Issue 4, 1997, Pages 19-22

  Boguszewski, C L ^a   Carlsson, B ^a   Carlsson, L M S ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bioinactive GH; Children; Growth failure; Growth hormone sensitivity

Indexed keywords

GROWTH HORMONE;

CHILD; CLINICAL EXAMINATION; CONFERENCE PAPER; GENETIC DISORDER; GROWTH DISORDER; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; GROWTH REGULATION; GROWTH RETARDATION; HUMAN; MOLECULAR BIOLOGY; PRIORITY JOURNAL; SHORT STATURE;

CHILD; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; MODELS, BIOLOGICAL;

EID: 0030662367     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000191307     Document Type: Article

References (26)

1. Guyda HJ: Use of growth hormone in children with short stature and normal growth hormone secretion: A growing problem. Trends Endocrinol Metab 1994:5:334-340.
2. Wit J-M. Boersma B. de Muinck Keizer-Schra-ma SMPF. Nienhuist HE. Oostdijk W. Otten BJ. Delemarre-Van de Waal HA. Reeser M, Waelkens JJJ. Rikken B, Massa GG: Longterm results ofgrowth hormone therapy in children with short stature, subnormal growth rate and normal growth hormone response to sccrc-tagogues. Clin Endocrinol 1995:42:365-372.
3. Mullis PE, Argente J. Amsclem S. Pfaffle R, Van der Burgt I: Genetics and molecular biology in short stature. Acta Paediatr 1995;84 (suppl 411):75-80.
4. Laron Z: Prismatic cases: Laron syndrome (primary growth hormone resistance) from patient to laboratory to patient. J Clin Endocrinol Metab 1995:80:1526-1531.
5. Rosenfeldl RG. Roscnbloom AL. Guevara-Aguirre J: Growth hormone (GH) insensitivity due to primary GH receptor deficiency. Endocr Rev 1994:15:369-390.
6. Carlsson LMS: Partial GH insensitivity in childhood: in Savage MO, Ross RJM (eds): Bailliere's Clinical Endocrinology and Metabolism (Growth Hormone Resistance). London, WB Saunders, 1996. pp 389-400.
7. Carlsson LMS. Rowland AM. Clark RG, Ge-sundheil N, Wong WLT: Ligand-mediated im-munofunctional assay (LIFA) for quantitation of growth hormone binding protein in human blood. J Clin Endocrinol Metab 1991:73:1216-1223.
8. Carlsson LMS. Attic KM. Compton PG. Vitangcol RV, Mcrimee TJ: Reduced concentration of serum growth hormone-binding protein in children with idiopathic short stature. J Clin Endocrinol Metab 1994:78:1325-1330.
9. Mauras N, Carlsson LMS. Murphy S, Merimec TJ: Growth hormone-binding protein levels: Studies of children with short stature. Metabolism 1994;43:357-359.
10. Bjamason R, Albertsson-Wikland K, Carlsson LMS: Acute and chronic effects of subcutaneous growth hormone (GH) injections on plasma levels of GH binding protein in short children. J Clin Endocrinol Metab 1995:80: 2756-2760.
11. Fontoura M. Mugnier E. Brauner R. Rappaport R. Postel-Vinay M-C: Effect of growth hormone on the low level of growth hormone binding protein in idiopathic short stature. Clin Endocrinol 1992;37:249-253.
12. Goddard AD. Covello R, Luoh SM. Clackson T. Attie KM. Gesundheit N, Rundle AC. Wells JA. Carlsson LMS: Growth hormone receptor mutations in idiopathic short stature. N Engl J Med 1995;333:1093-1098.
13. Woods KA. Camacho-Hübner C. Savage MO. Clark AJL: Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl J Med 1996;335:1363-1367.
14. Ross RJM. Chew SL: Acquired growth hormone resistance. Eur J Endocrinol 1995:132: 655-660.
15. Hermansson M. Wickelgren RB. Hammarqvist F, Bjamason R. Wennström I. Werncrman J. Carlsson B, Carlsson LMS: Measurement of human growth hormone receptor messenger ribonucleic acid by a quantitative polymerase chain reaction-based assay: Demonstration of reduced expression after elective surgery. J Clin Endocrinol Metab 1997:82:421-428.
16. Kowarski AA. Schneider J, Ben-Galim E, Weldon VV. Daughaday WH: Growth failure with normal serum R1A-GH and low somatomedin activity: Somatomedin restoration and growth acceleration after exogenous GH. J Clin Endocrinol Metab 1978;47:461-464.
17. Havek A. Peake GT. Greenberg RE: A new syndrome of short stature due to biologically inactive but immunoreactive growth hormone. Pediatr Res 1978:12:413.
18. Plotnick LP, Van Meter QL, Kowarski AA: Human growth hormone treatment of children with growth failure and normal growth hormone levels by immunoassay: Lack of correlation with somatomedin generation. Pediatrics 1983;71:324-327.
19. Bright GM. Rogol AD. Johanson AJ. Blizzard RM: Short stature associated with normal growth hormone and decreased somatomedin-C concentrations: Response to exogenous growth hormone. Pediatrics 1983;71:576-580.
20. Valenta U, Sigel MB, Lesniak MA, Elias AN, Lewis UJ, Friesen HG, Kershnar AK: Pituitary' dwarfism in a patient with circulating abnormal growth hormone polymers. N Engl J Med 1985:312:214-217.
21. Takahashi Y, Kaji H, Okimura Y, Goji K, Abe H, Chihara K: Short stature caused by a mutant growth hormone. N Engl J Med 1996:334:432-436.
22. Coffin V. Shiverick KT. Kelly PA. Martial JA: Scquencc-function relationships within the expanding family of prolactin, growth hormone, placental lactogen, and related proteins in mammals. Endocr Rev 1996;17:385-410.
23. Boguszewski CL, Hvnsjö L. Johansson G, Bengtsson B-À, Carlsson LMS: 22-kD Growth hormone exclusion assay: A new approach to measurement of non-22 kD growth hormone isoforms in human blood. Eur J Endocrinol 1996;135:573-582.
24. Boguszewski CL. Jansson C, Carlsson B. Boguszewski MCS. Albertsson- Wikland K. Carlsson LMS: Increased amounts of non-22kDa GH isoforms in prepubertal children small for gestational age (SGA) and girls with Turner syndrome. Endocrinol Metab 1997;4(suppl A): 15.
25. Daltani MT, Hindmarsch PC, Pringle PJ, Brook CG. Marshall NJ: The measurement of growth hormone bioactivity in patient serum using an eluted stain assay. J Clin Endocrinol Metab 1995;80:2675-2683.
26. Strasburger CJ, Wu Z, Pflaunt C-D, Dressendörfer RA: Immunofunctional assay of human growth hormone (hGH) in serum: A possible consensus for quantitative hGH measurement. J Clin Endocrinol Metab 1996:81:2613-2620.